PRTN3 promotes IL33/Treg-mediated tumor immunosuppression by enhancing the M2 polarization of tumor-associated macrophages in lung adenocarcinoma
Cancer Letters · 2025-04 · 616 · 217584
DOI: 10.1016/j.canlet.2025.217584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025-04. Verfasst von Jiayu Jiang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical Co…. Hauptthemen laut MEDLINE: Tumor-Associated Macrophages, Interleukin-33, T-Lymphocytes, Regulatory, Adenocarcinoma of Lung. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China.
Abstract (Originalsprache)
The immunosuppressive tumor microenvironment (TME) shaped by tumor-associated macrophages (TAMs) is essential for lung adenocarcinoma (LUAD) immune tolerance and tumor progression. Here, we first reported that proteinase 3 (PRTN3) promoted the alternative activation (M2) of TAMs and enhanced IL33/regulatory T cells (Tregs)-mediated tumor immunosuppression in LUAD. Firstly, clinical analysis revealed PRTN3 was highly expressed in TAMs and correlated with the tumor progression and poor prognosis in LUAD patients. Meanwhile, by using the myeloid cells-specific Prtn3-knockout mouse model, we demonstrated Prtn3 deficiency in macrophages remolded the immunosuppressive TME and suppressed tumor growth. The mechanism studies uncovered a novel signaling pathway that PRTN3 up-regulated IL33 expression in TAMs by suppressing AKT-mediated ubiquitinated degradation of FOXO1, which subsequently activated Il33 transcription. Furthermore, lack of PRTN3 or FOXO1 in macrophages greatly restrained IL33-induced Treg differentiation. Importantly, selective knockout of Prtn3 in macrophages significantly enhanced the antitumor effect of anti-PD1 therapy in the mouse model of LUAD. Thus, our work demonstrated that PRTN3 in macrophages, served as a key immunoregulator, contributed to impede the antitumor immune response through reinforcing the TAMs/Tregs crosstalk, which provided valuable insights to improve the immunotherapeutic effect by functional remodeling of TAMs to alleviate immunosuppression in LUAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China; Collaborative Innovation Center for Bio…
- Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, 300052, China.
- Changzhou Xitaihu Institute for Frontier Technology of Cell Therapy, Changzhou, 213149, China; The School of Medicine, Nankai University, Tianjin, 300071, China.
- Immunology Research Center, National Health Research Institutes, Miaoli, Zhunan, Taiwan.
Förderung
- Innovative Research Group Project of the National Natural Science Foundation of China
Zitieren
APA
Jiang, J., Chen, H., Zhao, C., Li, T., Zhang, C., Ma, L., Su, H., Ma, L., Duan, Z., Si, Q., Chuang, T. H., Chen, C., & Luo, Y. (2025). PRTN3 promotes IL33/Treg-mediated tumor immunosuppression by enhancing the M2 polarization of tumor-associated macrophages in lung adenocarcinoma. Cancer Letters, 616, 217584. https://doi.org/10.1016/j.canlet.2025.217584
Vancouver
Jiang J, Chen H, Zhao C, Li T, Zhang C, Ma L, et al. PRTN3 promotes IL33/Treg-mediated tumor immunosuppression by enhancing the M2 polarization of tumor-associated macrophages in lung adenocarcinoma. Cancer Letters. 2025;616:217584. doi:10.1016/j.canlet.2025.217584
BibTeX
@article{Jiang2025,
author = {Jiang, Jiayu and Chen, Huilin and Zhao, Chunxing and Li, Tong and Zhang, Chen and Ma, Lingyu and Su, Huifang and Ma, Lei and Duan, Zhaojun and Si, Qin and Chuang, Tsung-Hsien and Chen, Chong and Luo, Yunping},
title = {PRTN3 promotes IL33/Treg-mediated tumor immunosuppression by enhancing the M2 polarization of tumor-associated macrophages in lung adenocarcinoma},
journal = {Cancer Letters},
year = {2025},
volume = {616},
pages = {217584},
doi = {10.1016/j.canlet.2025.217584}
}
EUVIMED